Alternative Targets for Immunotherapy: Targeting CD22 With Monoclonal Antibodies for the Treatment of Non-Hodgkin?s Lymphoma

Reporter: William Levin, MD
The University of Pennsylvania
Ultima Vez Modificado: 8 de diciembre del 2001

Translation for this article does not exist

Blogs

Cancer and Hair Loss
by Bob Riter
February 11, 2016